Von Willibrand’s Disease: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
[https://pubmed.ncbi.nlm.nih.gov/31902122/ Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience] | [https://pubmed.ncbi.nlm.nih.gov/31902122/ Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience] | ||
Federici AB. Clinical and laboratory diagnosis of VWD. Hematology Am Soc Hematol Educ Program. 2014 Dec; 2014(1): 524-30. PMID: 25696905 | |||
Neff AT, Sidonio RF Jr. Management of VWD. Hematology Am Soc Hematol Educ Program. 2014 Dec; 2014(1): 536-41. PMID: 25696907 | |||
Latest revision as of 18:46, 15 June 2026
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Relevant Article Depot:
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease
Federici AB. Clinical and laboratory diagnosis of VWD. Hematology Am Soc Hematol Educ Program. 2014 Dec; 2014(1): 524-30. PMID: 25696905
Neff AT, Sidonio RF Jr. Management of VWD. Hematology Am Soc Hematol Educ Program. 2014 Dec; 2014(1): 536-41. PMID: 25696907